AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteGNE-7915 is a Blood-Brain Barrier (BBB) penetrable small molecule inhibitor of Leucine-Rich Repeat Kinase 2 (LRRK2).
More Information Supplier PageGNE-7915 is a Blood-Brain Barrier (BBB) penetrable small molecule inhibitor of Leucine-Rich Repeat Kinase 2 (LRRK2).
More Information Supplier PageGNE-900 is an ATP-competitive, selective, and orally bioavailable ChK1 inhibitor.
More Information Supplier PageGNE-900 is an ATP-competitive, selective, and orally bioavailable ChK1 inhibitor.
More Information Supplier PageGNE-900 is an ATP-competitive, selective, and orally bioavailable ChK1 inhibitor.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
More Information Supplier PageGNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
More Information Supplier PageGNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
More Information Supplier PageGNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
More Information Supplier PageGNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.
More Information Supplier PageGo 6976 is a potent protein kinase C (PKC) inhibitor (IC50 = 7.9 nM).
More Information Supplier PageGo 6976 is a potent protein kinase C (PKC) inhibitor (IC50 = 7.9 nM).
More Information Supplier PageGo 6976 is a potent protein kinase C (PKC) inhibitor (IC50 = 7.9 nM).
More Information Supplier PageGo 6976 is a potent protein kinase C (PKC) inhibitor (IC50 = 7.9 nM).
More Information Supplier PageGo 6976 is a potent protein kinase C (PKC) inhibitor (IC50 = 7.9 nM).
More Information Supplier PageGO6983 is a potent protein kinase C (PKC) inhibitor. It reduces polymorphonuclear leukocyte adherence and infiltration following myocardial ischemia/reperfusion injury.
More Information Supplier PageGO6983 is a potent protein kinase C (PKC) inhibitor. It reduces polymorphonuclear leukocyte adherence and infiltration following myocardial ischemia/reperfusion injury.
More Information Supplier PageGO6983 is a potent protein kinase C (PKC) inhibitor. It reduces polymorphonuclear leukocyte adherence and infiltration following myocardial ischemia/reperfusion injury.
More Information Supplier PageGO6983 is a potent protein kinase C (PKC) inhibitor. It reduces polymorphonuclear leukocyte adherence and infiltration following myocardial ischemia/reperfusion injury.
More Information Supplier PageGolotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities.
More Information Supplier PageGolotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities.
More Information Supplier PageGolotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities.
More Information Supplier PageGossypol is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes.
More Information Supplier PageGossypol is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes.
More Information Supplier PageGossypol is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes.
More Information Supplier PageGossypol is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes.
More Information Supplier PageGPR120 modulator 1 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGPR120 modulator 1 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGPR120 modulator 1 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGPR120 modulator 2 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGPR120 modulator 2 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGPR120 modulator 2 is useful for modulating G protein-coupled receptor 120 (GPR120).
More Information Supplier PageGR 103691 is an effective and selective receptor antagonist of the dopamine D3 receptor (D3DR).
More Information Supplier PageGR 103691 is an effective and selective receptor antagonist of the dopamine D3 receptor (D3DR).
More Information Supplier Page
